These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24148752)

  • 61. The efficacy of open nephron-sparing surgery in the treatment of complex renal cell carcinoma.
    Liu TY; Li J; Wen XH; Zhang H; Gui Q
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3959-3964. PubMed ID: 27775806
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
    Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
    Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trends from 1999 to 2007 in the surgical treatments of kidney cancer in Europe: data from the Veneto Region, Italy.
    Fedeli U; Novara G; Alba N; Ficarra V; Artibani W; Spolaore P
    BJU Int; 2010 May; 105(9):1255-9. PubMed ID: 19818073
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.
    Butler BP; Novick AC; Miller DP; Campbell SA; Licht MR
    Urology; 1995 Jan; 45(1):34-40; discussion 40-1. PubMed ID: 7817478
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.
    Scosyrev E; Messing EM; Sylvester R; Campbell S; Van Poppel H
    Eur Urol; 2014 Feb; 65(2):372-7. PubMed ID: 23850254
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Partial nephrectomy vs. radical nephrectomy for stage I renal cell carcinoma in the presence of predisposing systemic diseases for chronic kidney disease.
    Demir Ö; Bozkurt O; Çelik S; Çömez K; Aslan G; Mungan U; Çelebi İ; Esen A
    Kaohsiung J Med Sci; 2017 Jul; 33(7):339-343. PubMed ID: 28738974
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Laparoendoscopic single-site versus conventional laparoscopic radical nephrectomy for renal cell cancer in patients with increased comorbidities and previous abdominal surgery: preliminary results of a single-centre retrospective study.
    Springer C; Inferrera A; Kawan F; Schumann A; Fornara P; Greco F
    World J Urol; 2013 Feb; 31(1):213-8. PubMed ID: 23242034
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of renal surgery for cortical neoplasms on lipid metabolism.
    Bagrodia A; Kopp RP; Mehrazin R; Lee HJ; Liss MA; Jabaji R; Kane CJ; Wake RW; Patterson AL; Wan JY; Derweesh IH
    BJU Int; 2014 Dec; 114(6):837-43. PubMed ID: 24656182
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
    World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series.
    Sengupta S; Zincke H; Leibovich BC; Blute ML
    BJU Int; 2005 Jul; 96(1):54-7. PubMed ID: 15963120
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A snapshot of nephron-sparing surgery in Italy: a prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project).
    Schiavina R; Mari A; Antonelli A; Bertolo R; Bianchi G; Borghesi M; Brunocilla E; Fiori C; Longo N; Martorana G; Mirone V; Morgia G; Novara G; Porpiglia F; Rovereto B; Serni S; Simeone C; Sodano M; Terrone C; Carini M; Minervini A
    Eur J Surg Oncol; 2015 Mar; 41(3):346-52. PubMed ID: 25583459
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
    Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
    J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Renal lesions with low R.E.N.A.L nephrometry score are associated with more indolent renal cell carcinomas (RCCs) or benign histology: findings in an Australian cohort.
    Satasivam P; Sengupta S; Rajarubendra N; Chia PH; Munshey A; Bolton D
    BJU Int; 2012 Apr; 109 Suppl 3():44-7. PubMed ID: 22458493
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
    Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center.
    Andrade HS; Zargar H; Akca O; Kara O; Caputo PA; Ramirez D; Andrés G; Stein RJ; Chueh SJ; Kaouk JH
    J Endourol; 2017 Feb; 31(2):153-157. PubMed ID: 27881027
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Trend of Surgical Treatment of Localized Renal Cell Carcinoma.
    Jabaji RB; Fischer H; Kern T; Chien GW
    Perm J; 2019; 23():18-108. PubMed ID: 30624203
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
    Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
    BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.